Fresh Tracks Therapeutics IncOver The Counter Market:FRTX
- LAST PRICE0.7200
- TODAY'S CHANGE (%)0.0050 (0.6993%)
- Bid / Lots---/ ---
- Ask / Lots---/ ---
- Open / Previous Close0.7200 / 0.7150
- Day Range
- 52 Week Range
- Volume1,128
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FRTX |
|---|---|---|
| 09:32 ET | 185 | 0.72 |
| 10:02 ET | 178 | 0.72 |
| 10:29 ET | 155 | 0.72 |
| 10:40 ET | 333 | 0.72 |
| 01:13 ET | 111 | 0.72 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Fresh Tracks Therapeutics Inc | 4.3M | -0.5x | --- |
Correlate Energy Corp | 5.2M | -0.2x | --- |
International Stem Cell Corp | 960.5K | -1.8x | --- |
VBI Vaccines Inc | 14.3K | 0.0x | --- |
BioNexus Gene Lab Corp | 5.2M | -6.8x | --- |
Rosetta Genomics Ltd | 590.0 | 0.0x | --- |
Company Information
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.
Contact Information
- Headquarters
- 2000 CENTRAL AVENUE, SUITE 100BOULDER, CO, United States 80301
- Phone
- 720-505-4755
- Fax
- 302-655-5049
Executives
- Chief Executive Officer, Chief Financial Officer, Company Secretary, Director
- Albert Marchio
- Chief Operating Officer, Chief Research and Development Officer
- Deepak Chadha
- Chief Accounting Officer, Vice President - Finance
- Aaron Fox-Collis
- Chief Compliance Officer, General Counsel, Company Secretary
- David McAvoy
- Independent Director
- Vijay Samant
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $4.3M |
|---|---|
Revenue (TTM) | $8.0M |
Shares Outstanding | 6.0M |
Fresh Tracks Therapeutics Inc does not pay a dividend. | |
Beta | 0.50 |
EPS | $-1.38 |
Book Value | $1.66 |
P/E Ratio | -0.5x |
Price/Sales (TTM) | 0.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -79.44% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
